Pharmacokinetics, resistance, and toxicity of linezolid in drug-resistant tuberculosis
The Stephen Lawn Memorial Fund funds the Stephen Lawn TB-HIV Research Leadership Prize for an early researcher conducting work focused on reducing the disease burden of HIV associated TB in Africa. We are delighted to announce that this year's winner, Dr Sean Wasserman will be delivering a lunchtime seminar on "Pharmacokinetics, resistance, and toxicity of linezolid in drug-resistant tuberculosis".
Dr Sean Wasserman completed his medical degree as well as post-graduate training at the University of Cape Town. He is a Fellow of the College of Physicians and Infectious Diseases at the Colleges of Medicine of South Africa. Dr Wasserman is based in the Department of Medicine at Groote Schuur Hospital and the University of Cape Town as a Consultant and Associate Professor in Infectious Diseases. He is a Contributing Investigator at the Wellcome Centre for Infectious Diseases Research in Africa, where his main research areas are new and repurposed drugs for tuberculosis (TB), with a focus on pharmacokinetics (PK) and resistance, and novel regimens and PK in TB meningitis. Other interests include HIV-associated pneumocystis pneumonia, Staphylococcus aureus bacteraemia, and antibiotic stewardship. In 2019 he was awarded the TB Union’s Stephen Lawn TB-HIV Research Leadership Prize, as well as the Institut Mérieux and Infectious Diseases Society of Southern Africa Young Investigator Award.